These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11485664)

  • 21. Protection of human subjects. Time for reassessment.
    Foley G
    Cancer Pract; 1999; 7(5):220. PubMed ID: 10687589
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ethics committees: international experience and of the National Institute for cancer research of Genoa].
    Sinaccio G; Robert E; Corda A; Dagnino G; Rosmino E; Gipponi M
    Minerva Med; 1990 Dec; 81(12):869-73. PubMed ID: 2280878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of human subjects in experimentation. Institutional review boards: purposes, protocols, legal responsibilities.
    Knepper JD
    J Am Med Rec Assoc (1980); 1982 Oct; 53(5):97-101. PubMed ID: 10298700
    [No Abstract]   [Full Text] [Related]  

  • 24. Nontherapeutic research on subjects unable to grant consent.
    Frank S; Agich GJ
    Clin Res; 1985 Oct; 33(4):459-64. PubMed ID: 4053504
    [No Abstract]   [Full Text] [Related]  

  • 25. Inconsistency and institutional review boards.
    Goldman J; Katz MD
    JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Variation and inconsistency in the evaluation of experiments by medical ethics committees].
    Bergkamp L
    Ned Tijdschr Geneeskd; 1989 Mar; 133(9):446-9. PubMed ID: 2710252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The institutional review board: an evolving ethics committee.
    Lind SE
    J Clin Ethics; 1992; 3(4):278-82. PubMed ID: 1463879
    [No Abstract]   [Full Text] [Related]  

  • 28. Problems with Institutional Review Board inconsistency.
    Veatch RM
    JAMA; 1982 Jul; 248(2):179-80. PubMed ID: 7045427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remodelling IRBs.
    Silberner J
    Hastings Cent Rep; 1998; 28(4):5. PubMed ID: 9762532
    [No Abstract]   [Full Text] [Related]  

  • 30. The institutional review board and beyond: future challenges to the ethics of human experimentation.
    Edgar H; Rothman DJ
    Milbank Q; 1995; 73(4):489-506. PubMed ID: 7491097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Institutional review boards: informed consent and clinical trial ethics.
    Hunter TH
    Drug Inf J; 1982; 16(1-2):56-9. PubMed ID: 10260016
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research ethics and new diagnostic technologies.
    Weber LJ; Bissell MG
    Clin Lab Manage Rev; 1996; 10(2):182-4. PubMed ID: 10172602
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience with boards and commissions concerned with research ethics in the United States.
    McCarthy CR
    Prog Clin Biol Res; 1983; 128():111-22. PubMed ID: 6634724
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethics and human experimentation. Henry Beecher revisited.
    Rothman DJ
    N Engl J Med; 1987 Nov; 317(19):1195-9. PubMed ID: 3309660
    [No Abstract]   [Full Text] [Related]  

  • 36. Institutional review boards and the freedom to take risks.
    Pattullo EL
    N Engl J Med; 1982 Oct; 307(18):1156-9. PubMed ID: 7121543
    [No Abstract]   [Full Text] [Related]  

  • 37. Is informed consent always necessary for randomized, controlled trials?
    Carome MA
    N Engl J Med; 1999 Aug; 341(6):448-9; author reply 450. PubMed ID: 10438260
    [No Abstract]   [Full Text] [Related]  

  • 38. Developing regulations for research involving adults who lack decision-making capacity.
    Fleischman AR
    Trans Am Clin Climatol Assoc; 1999; 110():131-43; discussion 143-5. PubMed ID: 10344013
    [No Abstract]   [Full Text] [Related]  

  • 39. Defining and describing benefit appropriately in clinical trials.
    King NM
    J Law Med Ethics; 2000; 28(4):332-43. PubMed ID: 11317426
    [No Abstract]   [Full Text] [Related]  

  • 40. Research policy for nursing services: Part 2.
    Hodgman EC
    J Nurs Adm; 1981 May; 11(5):33-6. PubMed ID: 6915095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.